The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients. - Test2 - elhamkhani - TriplyDB

The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients.

The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients.

http://www.wikidata.org/entity/Q37589021

about

The efficacy of gaseous ozone against different forms of Candida albicans.Candiduria; a review article with specific data from Iran

P2860

Q47707544-B814B0E1-0128-4C22-81BD-56034198A8A7 Q58702734-D41EE4BE-E93E-4086-B14D-A2E344313474

P2860

The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients.

http://www.wikidata.org/entity/Q37589021

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Frequency, Antifungal Susc ...... ted from Neutropenic Patients.

@en

The Frequency, Antifungal Susc ...... ted from Neutropenic Patients.

@nl

type

label

The Frequency, Antifungal Susc ...... ted from Neutropenic Patients.

@en

The Frequency, Antifungal Susc ...... ted from Neutropenic Patients.

@nl

prefLabel

The Frequency, Antifungal Susc ...... ted from Neutropenic Patients.

@en

The Frequency, Antifungal Susc ...... ted from Neutropenic Patients.

@nl

P1433

Q37589021-9D8383BB-AA5A-4548-8936-A2D899321C35

P1476

Q37589021-DAC12C47-51C1-4AE8-A993-C75612479E35

P2860

Q37589021-026FBDDC-EB4E-47FA-B617-D94FA98F39C8

Q37589021-152FEEB6-1B2C-4401-9345-36F3C6FF4FB1

Q37589021-1890C90E-3F51-45EE-9ED4-1CD3DC0A37C5

Q37589021-2A931105-7456-411C-86D7-3F91A6D710D7

Q37589021-3D5A9A26-AD47-4E97-B456-098E69463F96

Q37589021-3E102C19-3DF3-4342-B065-5878E22B3ADD

Q37589021-46C069D3-D626-4ABD-85CA-4F638419921F

Q37589021-52156F75-AA7F-45D1-B138-F213B22E1165

Q37589021-5DF6A40C-0F44-4C6A-B381-8CCEE70BAF23

Q37589021-612B686B-032D-49A6-AB0B-B7D37B603E22

P304

Q37589021-DF16DB15-43BC-459B-80F0-A0A3C557A893

P31

Q37589021-F4C0484F-3B1F-4980-861E-76413B28A776

P356

Q37589021-EF7AD5CE-3004-49FF-BAC3-D97B7C614151

P433

Q37589021-BF4B2087-E44F-4AEE-A8B8-A7C2D44DCCCF

P478

Q37589021-0DCA23F5-C41A-4D25-8CF2-1C3AB07D41E2

P50

Q37589021-27ED0665-610C-47C0-A170-DAA186A22373

Q37589021-8C0AF27D-A713-4C5C-8AE7-2CC3FA433E30

Q37589021-B2BE0516-C80A-4A64-A1D5-33587F279DFF

Q37589021-E925750F-ABD0-49CB-8D87-D3C86554990F

P577

Q37589021-DA7F353A-309F-460D-B305-9A11E0055036

P698

Q37589021-0CBB493C-FF52-4E07-9B06-ACFA87C3344B

P932

Q37589021-9C864B92-07BF-4E55-95B2-9D9328076A63

P356

P1433

Jundishapur journal of microbiology JJM

P1476

The Frequency, Antifungal Susc ...... ted from Neutropenic Patients.

@en

P2860

Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia

A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

Screening of antifungal azole drugs and agrochemicals with an adapted alamarBlue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulcerans.

Emergence of resistant Candida in neutropenic patients.

Genetic diversity of medically important and emerging Candida species causing invasive infection.

Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals.

Antifungal agent utilization evaluation in hospitalized neutropenic cancer patients at a large teaching hospital.

Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy

Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.

P304

e41446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/JJM.41446

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Ali Rezaei-Matehkolaei

Maral Gharaghani

Ali Zarei Mahmoudabadi

P577

2016-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28138378

http://www.w3.org/2001/XMLSchema#string

P932

5240162

http://www.w3.org/2001/XMLSchema#string